MA-DESKTOP-METAL
11.7.2022 15:27:07 CEST | Business Wire | Press release
Desktop Metal (NYSE: DM), a global leader in additive manufacturing technologies for mass production, today announced it has expanded its relationship with CNC software innovator SolidCAM, creator of the breakthrough iMachining® toolpath technology and a leading distributor of solutions to precision metal manufacturers worldwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220711005464/en/
SolidCAM, which was founded in 1984, has offered Desktop Metal products in Germany since 2021. Now, it will offer Desktop Metal solutions for direct printing of metal to customers in the United States, where SolidCAM has technology centers at its US headquarters in Newton, Pa., and Rancho Cucamonga, CA, as well as the United Kingdom, Israel and India. In all, SolidCAM has about 100 direct sales team members worldwide.
Additionally, new CNC + AM Center of Excellence showrooms are currently being completed in Pennsylvania, Germany, and the UK to demonstrate how Desktop Metal’s AM 2.0 solutions complement traditional subtractive machining technology and workflows. Additional facilities are also slated for completion in California, Israel and India.
“The Desktop Metal team is delighted to announce an expansion of our relationship with SolidCAM, a brand that is long trusted by machinists worldwide,” said Ric Fulop, Founder and CEO of Desktop Metal. “This expanded partnership means that more CNC professionals will learn how easy it is to 3D print and sinter complex designs on our Studio System and Shop System metal AM offerings, freeing up capacity on CNC equipment, as well as machinist’s time. Additive manufacturing technology is truly complementary to machining, and we’re eager to deliver that message to the market in partnership with SolidCAM.”
“Our Schramberg Technology Center has already added a Desktop Metal Studio System to its current CNC machines, and we’re in the process of adding more Studio System and Shop System printers to our facilities worldwide so we can demonstrate how this additive manufacturing technology is complementary to CNC machining equipment,” said Dr. Emil Somekh, Founder and CEO of SolidCAM. “The growing impact of additive manufacturing has been well documented. During the COVID-19 epidemic, 3D printing played a critical role in repairing vulnerabilities in supply chains, especially in the medical sector, and we think it can help improve the throughput of supply chains that remain challenged today.”
SolidCAM will be showcasing Desktop Metal equipment and solutions in its booth at IMTS 2022 from Sept. 12 - 17 in Chicago in Booth No. 134502. Desktop Metal will also have two booths at the show, No. 433103 and 432212, where it will be showcasing its metal, polymer, and digital metal casting Additive Manufacturing 2.0 solutions. The International Manufacturing Technology Show, produced by the Association For Manufacturing Technology, is the largest and longest-running industry trade show in the Western Hemisphere.
About Desktop Metal
Desktop Metal, Inc., based in Burlington, Massachusetts, is accelerating the transformation of manufacturing with an expansive portfolio of 3D printing solutions, from rapid prototyping to mass production. Founded in 2015 by leaders in advanced manufacturing, metallurgy, and robotics, the company is addressing the unmet challenges of speed, cost, and quality to make additive manufacturing an essential tool for engineers and manufacturers around the world. Desktop Metal was selected as one of the world’s 30 most promising Technology Pioneers by the World Economic Forum, named to MIT Technology Review’s list of 50 Smartest Companies, and the 2021 winner of Fast Company’s Innovation by Design Award in materials and Fast Company’s Next Big Things in Tech Award for sustainability.
About SolidCAM
SolidCAM is recognized as the world leader in seamless integration of CAM in leading CAD products, SolidWorks and Inventor, supporting the complete range of CNC manufacturing applications, including iMachining 2D/3D, 2.5D milling, high-speed surface milling, 3D high-speed machining, multi-sided indexial 4/5 axes milling, simultaneous 5 axes milling, multi-channel mill-turn, Swiss-type machining and probing. SolidCAM has been a consistent growth leader in CAM. Along with its worldwide branches and affiliates direct sales channels, SolidCAM has a worldwide CAM reseller network, in over 50 countries. The SolidCAM industrial user base includes today more than 24,000 seats.
Forward-looking Statements
This press release contains certain forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including but not limited to, the risks and uncertainties set forth in Desktop Metal, Inc.'s filings with the U.S. Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Desktop Metal, Inc. assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220711005464/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom